Lake Street analyst Ben Klieve raised the firm’s price target on Vital Farms (VITL) to $60 from $50 and keeps a Buy rating on the shares following an “across-the-board beat” in Q2 and full-year guidance being increased. There is “little to pick at in the report or from the earnings call,” says the analyst, who calls Vital the “highest conviction small cap investment opportunity in the food chain today.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms price target raised to $48 from $42 at TD Cowen
- Vital Farms price target raised to $48 from $41 at Morgan Stanley
- Vital Farms price target raised to $50 from $44 at BMO Capital
- Vital Farms: Strong Market Performance and Strategic Growth Drive Buy Rating
- Vital Farms Reports Strong Q2 2025 Growth